Molecular Therapy Family of Journals (@moltherapy.bsky.social)

Molecular Therapy Family Highlights Recombinant adeno-associated virus (rAAV) is one of the most popular gene therapy vectors and is used in >300 ongoing clinical trials. However, efficient, cost-effective, and scalable manufacturing of rAAV for clinical use remains a significant challenge. Current rAAV manufacturing relies upon batch production using HEK293 cells or the insect cell/baculovirus expression system (IC/BEVS), which can result in inconsistent product quality between batches and reduced productivity. By contrast, continuous production processes offer increased productivity, consistent product quality, and shorter turnaround times. http://dlvr.it/TSgkl5